Literature DB >> 21476100

Phosphatidylinositol-3-kinase activity during in vitro dendritic cell generation determines suppressive or stimulatory capacity.

Valentina Di Caro1, Antonella D'Anneo, Brett Phillips, Carl Engman, Jo Harnaha, Massimo Trucco, Nick Giannoukakis.   

Abstract

Modulating PI3K at different stages of dendritic cells (DC) generation could be a novel means to balance the generation of immunosuppressive versus immunostimulatory DC. We show that PI3K inhibition during mouse DC generation in vitro results in cells that are potently immunosuppressive and characteristic of CD8alpha- CD11c+ CD11b+ DC. These DC exhibited low surface class I and class II MHC, CD40, and CD86 and did not produce TNF-alpha. In allogeneic MLR, these DC were suppressive. Although in these mixed cultures, there was no increase in the frequency of CD4+ CD25+ Foxp3+ cells, the Foxp3 content on a per cell basis was significantly increased. Sustained TLR9 signaling in the presence of PI3K inhibition during DC generation overrode the cells' suppressive phenotype.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21476100     DOI: 10.1007/s12026-011-8206-1

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  140 in total

Review 1.  The role of PI3K in immune cells.

Authors:  Shigeo Koyasu
Journal:  Nat Immunol       Date:  2003-04       Impact factor: 25.606

Review 2.  Pharmacological induction of tolerogenic dendritic cells and regulatory T cells.

Authors:  Luciano Adorini; Nadia Giarratana; Giuseppe Penna
Journal:  Semin Immunol       Date:  2004-04       Impact factor: 11.130

3.  SHIP negatively regulates Flt3L-derived dendritic cell generation and positively regulates MyD88-independent TLR-induced maturation.

Authors:  Frann Antignano; Mariko Ibaraki; Jens Ruschmann; Julienne Jagdeo; Gerald Krystal
Journal:  J Leukoc Biol       Date:  2010-08-18       Impact factor: 4.962

4.  Human monocyte isolation methods influence cytokine production from in vitro generated dendritic cells.

Authors:  Eyad Elkord; Paul E Williams; Howard Kynaston; Anthony W Rowbottom
Journal:  Immunology       Date:  2005-02       Impact factor: 7.397

5.  Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase.

Authors:  David H Munn; Madhav D Sharma; Jeffrey R Lee; Kanchan G Jhaver; Theodore S Johnson; Derin B Keskin; Brendan Marshall; Phillip Chandler; Scott J Antonia; Russell Burgess; Craig L Slingluff; Andrew L Mellor
Journal:  Science       Date:  2002-09-13       Impact factor: 47.728

Review 6.  Plasmacytoid dendritic cells in autoimmune diabetes - potential tools for immunotherapy.

Authors:  Tatjana Nikolic; Jojanneke M C Welzen-Coppens; Pieter J M Leenen; Hemmo A Drexhage; Marjan A Versnel
Journal:  Immunobiology       Date:  2009-07-22       Impact factor: 3.144

7.  Generation of functional human dendritic cells from adherent peripheral blood monocytes by CD40 ligation in the absence of granulocyte-macrophage colony-stimulating factor.

Authors:  P Brossart; F Grünebach; G Stuhler; V L Reichardt; R Möhle; L Kanz; W Brugger
Journal:  Blood       Date:  1998-12-01       Impact factor: 22.113

8.  IFN-gamma synergizes with LPS to induce nitric oxide biosynthesis through glycogen synthase kinase-3-inhibited IL-10.

Authors:  Chiou-Feng Lin; Cheng-Chieh Tsai; Wei-Ching Huang; Chi-Yun Wang; Hsiang-Chi Tseng; Yi Wang; Jui-In Kai; Szu-Wen Wang; Yi-Lin Cheng
Journal:  J Cell Biochem       Date:  2008-10-15       Impact factor: 4.429

Review 9.  The PI3K/Akt/mTOR pathway in innate immune cells: emerging therapeutic applications.

Authors:  T Weichhart; M D Säemann
Journal:  Ann Rheum Dis       Date:  2008-12       Impact factor: 19.103

Review 10.  GSK-3 inhibitors and insulin receptor signaling in health, disease, and therapeutics.

Authors:  Akihiko Wada
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01
View more
  3 in total

Review 1.  In vivo delivery of nucleic acid-formulated microparticles as a potential tolerogenic vaccine for type 1 diabetes.

Authors:  Valentina Di Caro; Nick Giannoukakis; Massimo Trucco
Journal:  Rev Diabet Stud       Date:  2012-12-28

2.  Co-Stimulation-Impaired Bone Marrow-Derived Dendritic Cells Prevent Dextran Sodium Sulfate-Induced Colitis in Mice.

Authors:  Carl Engman; Yesica Garciafigueroa; Brett Eugene Phillips; Massimo Trucco; Nick Giannoukakis
Journal:  Front Immunol       Date:  2018-05-03       Impact factor: 7.561

Review 3.  Tolerogenic Dendritic Cells and T-Regulatory Cells at the Clinical Trials Crossroad for the Treatment of Autoimmune Disease; Emphasis on Type 1 Diabetes Therapy.

Authors:  Brett Eugene Phillips; Yesica Garciafigueroa; Carl Engman; Massimo Trucco; Nick Giannoukakis
Journal:  Front Immunol       Date:  2019-02-06       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.